Bibliographic Details
| Title: |
Discovery of LY2457546: a multi-targeted anti-angiogenic kinase inhibitor with a novel spectrum of activity and exquisite potency in the acute myelogenous leukemia-Flt-3-internal tandem duplication mutant human tumor xenograft model. |
| Authors: |
Burkholder TP; Discovery Chemistry Research and Technology, Eli Lilly and Company, Indianapolis, IN, USA. tpb@lilly.com, Clayton JR, Rempala ME, Henry JR, Knobeloch JM, Mendel D, McLean JA, Hao Y, Barda DA, Considine EL, Uhlik MT, Chen Y, Ma L, Bloem LJ, Akunda JK, McCann DJ, Sanchez-Felix M, Clawson DK, Lahn MM, Starling JJ |
| Source: |
Investigational new drugs [Invest New Drugs] 2012 Jun; Vol. 30 (3), pp. 936-49. Date of Electronic Publication: 2011 Mar 01. |
| Publication Type: |
Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: |
Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
